Head-to-head · WeighScore
KERNX Health vs Trimi
The verdict
Trimi takes it — 86.4/100 to 71.8/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | KERNX Health | Trimi |
|---|---|---|
| WeighScore | 71.8/100 | 86.4/100 |
| Grade | C | B |
| Site position | #98 | #4 |
| Semaglutide | $129/mo (compounded, plus a one-time consultation fee) | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | $229/mo (compounded, plus a one-time consultation fee) | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #98 · C
Strengths
- Prescribing clinicians are listed by name and credential rather than described as an anonymous "licensed provider network"
- A provider approves treatment before any charge is processed, and the site states plainly when it is not the right fit
- Monthly provider check-ins and a care team reachable seven days a week are included in the plan rather than sold as an upgrade
- The dose ladder is published for both molecules, so a dose escalation has a known price attached before it happens
Where it loses points
- The dispensing pharmacy is disclosed only in post-purchase paperwork, so no 503A or 503B status can be checked before you commit
- Lab work is not part of the program: it is recommended case by case, billed separately, and may be sent to your own provider
- Explicitly no health coaching or behavioral support — clinical oversight only
- Injectable compounded medication only, with no oral route and no FDA-approved brand pathway
- Cash-pay only, so nothing routes through insurance and no claim can be submitted for you
Site position #4 · B
Strengths
- Low flat pricing on both semaglutide and tirzepatide
- Both molecules on a single membership
- Free shipping to all 50 states
- Fast dispatch once the prescriber signs off
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- Injection only — no oral or sublingual route
- Dispensing pharmacy not publicly named
- Shorter public track record than the incumbents
Featured provider
Trimi
Trimi scores 86.4/100 (B). Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.